stopOverflowHandler
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Life sciences

Patents are now an essential part of the development of new products in Life Sciences. IP Overview helps you to better understand the competitive landscape in your field, to better understand the trends and analyse the maturity of an emerging market. 



€5 860.40 (including 19.6 % tax)

iPS cell Generation patent landscape - 2013/03

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged tissues using differentiated cells out of stem cells. However, ethical and scientific issues are related to the use of embryonic stem cells.  
Product Details...



€3 468.40 (including 19.6 % tax)

iPS Cells Diffentiation patent landscape - 2013/03

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged tissues using differentiated cells out of stem cells. However, ethical and scientific issues are related to the use of embryonic stem cells.  
Product Details...



€3 588.00 (including 19.6 % tax)

Monoclonal antibodies against digestive system cancers patent landscape - 2010/09

In order to fight digestive system cancers, monoclonal antibody-based therapies have recently reinforced the range of already marketed treatment...  
Product Details...



Food and beverage: French patent landscape – 2010/09

SPECIAL OFFER: If you want to receive this study (.pdf) for free, send us an e-mail at ipoverview@frinnov.fr With more than 4000 French priority patent applications filed during the last 20 years, the food and beverage industry is one of the most dynamic French fields with lots of small French companies investing in industrial property protection...  
Product Details...


€1 196.00 (including 19.6 % tax)

Nanoparticles for bioimaging patent landscape - 2010/05

In the current development of imaging technologies, new contrast agents and tracers are necessary to improve visualization.  
Product Details...



€1 196.00 (including 19.6 % tax)

HIV Therapy patent landscape - 2009/04

Discovered in 1983, the HIV virus has been the subject of intensive research and development within the academic and industrial sectors... 
Product Details...



€1 345.50 (including 19.6 % tax)

CDK Inhibitors patent landscape - 2009/10

One of the most exciting developments in the 90’s has been the elucidation of the molecular mechanisms that control the progression of cells through the division cycle. The cell-cycle progression is composed of two main phases, interphase and mitosis. It is controlled by a set of kinases in which cyclin dependent kinases (CDK) play a major role in triggering the cell cycle transitions.  
Product Details...



€1 495.00 (including 19.6 % tax)

Malaria patent landscape - 2009/07

With 300 to 500 million people suffering from Malaria, 1 to 3 million deaths every year and half of the world population at risk, malaria is the third most deadly infectious disease. 
Product Details...




  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»


Display #  
Results 1 - 8 of 8
 
 

Identification






 
   
viagra 100mg